Development of Inhalable Drugs

Aditya D. Surushe; Shubham R. Dudhe; Saad R. Shaikh; Priya U. Chikale; Pallavi Sambharkar

doi:10.55544/jrasb.3.6.20

Authors

Mr. Aditya D. Surushe Student Department of Pharmaceutics, SDMVM’s Diploma in Pharmacy Institute, Georai Tanda, Chhatrapati Sambhaji Nagar, Maharashtra, INDIA.
Mr. Shubham R. Dudhe Student Department of Pharmaceutics, SDMVM’s Diploma in Pharmacy Institute, Georai Tanda, Chhatrapati Sambhaji Nagar, Maharashtra, INDIA.
Mr. Saad R. Shaikh Student Department of Pharmaceutics, SDMVM’s Diploma in Pharmacy Institute, Georai Tanda, Chhatrapati Sambhaji Nagar, Maharashtra, INDIA.
Ms. Priya U. Chikale Guide Department of Pharmaceutics, SDMVM’s Diploma in Pharmacy Institute, Georai Tanda, Chhatrapati Sambhaji Nagar, Maharashtra, INDIA. https://orcid.org/0009-0002-9358-7279
Ms. Pallavi Sambharkar Guide Department of Pharmaceutics, SDMVM’s Diploma in Pharmacy Institute, Georai Tanda, Chhatrapati Sambhaji Nagar, Maharashtra, INDIA.

DOI:

https://doi.org/10.55544/jrasb.3.6.20

Keywords:

Inhalable drugs, drug delivery systems, nanoparticles, pulmonary administration, gene therapy, regulatory considerations

Abstract

Inhalable drug delivery systems have garnered significant interest in recent years due to their potential to provide targeted and efficient treatment for a wide range of respiratory and systemic diseases. This review provides an extensive overview of the types of inhalable drugs, their formulation challenges, delivery mechanisms, and the devices used for administration. It discusses physiological barriers, regulatory considerations, and the development of novel delivery systems, such as nanoparticles, smart polymers, and biologics. The article also examines the future directions of inhalable drug delivery, with a focus on personalized medicine, digital health, and advances in gene and cell therapies.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Rojan, N. et al., "Advanced Inhalable Drug Delivery Systems," Journal of Controlled Release, vol. 328, 2021, pp. 161-179.

Morais, J.G. et al., "Nanoparticles for Inhalation Therapy: Advances and Challenges," Journal of Nanomedicine & Nanotechnology, vol. 12, no. 2, 2020.

Nahar, K., and Gupta, N., "Inhalable Nanoparticulate Systems for Lung Cancer Therapy," Cancer Nanotechnology, vol. 12, 2021, pp. 123-134.

Yang, W., "Smart Polymers for Pulmonary Drug Delivery," Expert Opinion on Drug Delivery, vol. 18, no. 4, 2021, pp. 453-465.

FDA, "Inhalation Drug Products: Chemistry, Manufacturing, and Controls Documentation," U.S. Food and Drug Administration, 2020.

Laube, B. L., "The Expanding Role of Aerosols in Systemic Drug Delivery, Gene Therapy, and Vaccination," Respiratory Care, vol. 50, no. 9, 2005, pp. 1161-1176.

Patton, J. S., and Byron, P. R., "Inhaling Medicines: Delivering Drugs to the Body through the Lungs," Nature Reviews Drug Discovery, vol. 6, no. 1, 2007, pp. 67-74.

Lemarie, F., and Thiebaut, R., "Inhalable Formulations and Devices for Lung Cancer Treatment," International Journal of Pharmaceutics, vol. 604, 2021, pp. 120764.

Pison, U., "Nanocarriers as Inhalable Drug Delivery Systems," Expert Opinion on Drug Delivery, vol. 12, no. 12, 2015, pp. 1869-1880.

Mansour, H. M. et al., "Inhalation Aerosol Systems for Pulmonary Drug Delivery," Journal of Advanced Drug Delivery Reviews, vol. 64, no. 4, 2012, pp. 456-475.

Hoppentocht, M. et al., "Inhalable Antibacterial Agents in Pulmonary Infections," European Respiratory Journal, vol. 44, no. 3, 2014, pp. 820-833.

Carvalho, T. C., and McConville, J. T., "Formulations for Pulmonary Drug Delivery," International Journal of Pharmaceutics, vol. 392, no. 1-2, 2010, pp. 1-19.

Zhang, X. et al., "Aerosolized Liposomes for Pulmonary Drug Delivery," Journal of Advanced Drug Delivery Reviews, vol. 75, 2014, pp. 33-41.

Muralidharan, P., Hayes, D., and Mansour, H. M., "Dry Powder Inhalers in COPD, Lung Infections, and Asthma," Journal of Controlled Release, vol. 165, no. 2, 2013, pp. 129-138.

Leal, J., et al., "Nanoparticle-Based Drug Delivery Systems for Lung Diseases: Challenges and Opportunities," Journal of Nanobiotechnology, vol. 18, no. 1, 2020, pp. 1-24.

Taylor, K. M. G., and McCallion, O. N. M., "Pulmonary Drug Delivery Using Dry Powder Inhalers," Journal of Aerosol Medicine, vol. 9, no. 1, 1996, pp. 49-54.

Sung, J. C. et al., "Effect of Particle Size on Lung Deposition of Inhalation Therapies," Advanced Drug Delivery Reviews, vol. 64, no. 3, 2012, pp. 319-328.

Smith, I. J., and Parry-Billings, M., "The Inhalers of the Future?" Thorax, vol. 58, no. 8, 2003, pp. 660-664.

Wu, L., and Zhong, W., "Applications of Inhalable Nanoparticles in Drug Delivery Systems for Treating Pulmonary Diseases," Nanomedicine: Nanotechnology, Biology, and Medicine, vol. 12, no. 3, 2016, pp. 1239-1251.

Onishi, H., and Machida, Y., "Inhalable Drug Delivery Devices: Technologies and Recent Advances," Asian Journal of Pharmaceutical Sciences, vol. 13, no. 6, 2018, pp. 519-529.

Dalby, R. N. et al., "Advances in Dry Powder Inhaler Technology: Formulation, Device, and Therapeutic Considerations," AAPS PharmSciTech, vol. 17, no. 2, 2016, pp. 349-366.

McDonald, K. et al., "Inhalation Drug Delivery: Current Status and Future Trends," Therapeutic Advances in Chronic Disease, vol. 10, 2019, pp. 2040622319857994.

Kunda, N. K., and Somavarapu, S., "Nanoparticle-Based Inhalation Treatments for Lung Diseases," Pharmacological Research, vol. 154, 2020, pp. 104227.

Keller, M., and Wu, Y., "The Role of Particle Engineering in Inhalable Drug Delivery," Journal of Advanced Powder Technology, vol. 33, no. 2, 2022, pp. 100817.

Finlay, W. H., "The Mechanics of Inhaled Pharmaceutical Aerosols: An Introduction," Academic Press, 2001.

Edwards, D. A. et al., "A New Pulmonary Drug Delivery System: Dry Powder Inhalation of Inhalable Insulin," Science, vol. 276, 1997, pp. 1868-1871.

Sou, T. et al., "Design and Development of Aerosol Systems for Inhalable Drug Delivery," Journal of Pharmaceutical Sciences, vol. 102, no. 10, 2013, pp. 3656-3670.

He, C. et al., "Challenges and Innovations in Pulmonary Drug Delivery: Formulation, Devices, and Regulatory Approval," Drug Development and Industrial Pharmacy, vol. 47, no. 4, 2021, pp. 547-559.

Mahajan, M. et al., "Dry Powder Inhaler Development: Formulation Approaches and Regulatory Considerations," Pharmaceutics, vol. 12, no. 4, 2020, pp. 332-350.

Verma, R. et al., "Drug Delivery to the Lungs: Advances and Challenges," Journal of Aerosol Science, vol. 136, 2019, pp. 54-67.

Pilcer, G., and Amighi, K., "Formulation Strategy and Use of Excipient to Enhance Pulmonary Drug Delivery," International Journal of Pharmaceutics, vol. 392, 2010, pp. 1-19.

Forbes, B., and Ehrhardt, C., "Human Respiratory Epithelial Cell Culture for Drug Delivery Applications," Journal of Controlled Release, vol. 335, 2021, pp. 327-343.

Zhu, J. et al., "Inhaled Aerosols: Impacts on Drug Delivery and Lung Biology," Journal of Aerosol Medicine and Pulmonary Drug Delivery, vol. 32, no. 1, 2019, pp. 45-58.

Capretto, L., "Advances in Inhalation Therapy Devices: Innovation in Design," Journal of Biomedicine and Biotechnology, vol. 2015, 2015, Article ID 136795.

Geller, D. E., "Aerosol Antibiotics in Cystic Fibrosis," Respiratory Care, vol. 54, no. 5, 2009, pp. 658-670.

Gonda, I., "Aerosols for Drug Delivery to the Respiratory Tract," Critical Reviews in Therapeutic Drug Carrier Systems, vol. 7, no. 4, 1990, pp. 339-373.

Anderson, P. J., "History of Aerosol Therapy: Liquid, Solid, and Biological Aerosols," Respiratory Care, vol. 50, no. 9, 2005, pp. 1139-1151.

Alhnan, M. A. et al., "Emerging Concepts in the Development of Inhalable Biologics," Journal of Advanced Drug Delivery Reviews, vol. 144, 2019, pp. 120-137.

Mukherjee, S. et al., "Recent Progress in Inhalation Therapies: Pulmonary Fibrosis and COVID-19," Advanced Drug Delivery Reviews, vol. 169, 2021, pp. 1-22.

Tang, L. et al., "Advances in Nanoparticles-Based Inhalable Systems